⚠ Aufgrund von Wartungsarbeiten steht PubData am Dienstag, 17.11.2026, von 08:00 Uhr bis 13:00 Uhr nicht zur Verfügung.
⚠ Due to maintenance work, PubData will be unavailable on Tuesday, 17 November 2026, from 8.00 AM to 1.00 PM.
Journal ArticleParallel publicationPublished versionDOI: 10.48548/pubdata-4470

Eco-pharma dilemma: Navigating environmental sustainability trade-offs within the lifecycle of pharmaceuticals – A comment

Chronological data

Date of first publication2024-12-24
Date of publication in PubData 2026-10-15

Language of the resource

English

Related external resources

Variant form of DOI : 10.1016/j.scp.2024.101893
Moermond, C. T. A., Puhlmann, N., Pieters, L., Matharu, A., Boone, L., Dobbelaere, M., Proquin, H., Kümmerer, K., Ragas, A. M. J., Vidaurre, R., Venhuis, B., & De Smedt, D. (2025). Eco-pharma dilemma: Navigating environmental sustainability trade-offs within the lifecycle of pharmaceuticals – A comment. Sustainable Chemistry and Pharmacy, 43, Article 101893.
Published in ISSN : 2352-5541
Sustainable Chemistry and Pharmacy

Abstract

An ideal pharmaceutical treatment is both safe and effective for patients. However, from a sustainability perspective, it also needs to be cost-effective, energy- and resource-efficient, and not have a negative impact on the environment. When striving towards environmentally sustainable healthcare, trade-offs between environmental sustainability and other aspects play a multi-faceted role in decision-making along the whole life cycle of a pharmaceutical, from design to end-of-life. When making environment-driven choices, stakeholders in this life cycle (e.g., procurers, prescribers) may not be aware of all consequences (environmental, social, or economic), which complicates decision-making processes. Information at hand may be ambiguous or unknown due to data gaps, complex and interdependent local, national and global healthcare systems, and unknown future developments. Thus, trade-offs may happen at temporal or spatial scales outside of the daily practice of stakeholders. This commentary aims to initiate a discussion on these trade-offs, the need for a holistic view, the use of multi-criteria decision-making tools, and clear environmental sustainability guidelines.

Keywords

Pharmaceutical; Pharmaceutical Treatment; Sustainability; Environmental Impact; Holistic Assessment

Leuphana Institution

More information

DDC

Creation Context

Research